Guardant Health Inc (GH)

R&D Expenses

$96.53M

Quarterly · Period ending: · USD

GH logo

GH R&D Expenses

Latest reported$96.53M
GH Quarterly R&D Expenses ($5.34M → $96.53M)
High-resolution chart · PNG

GH r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Guardant Health Inc R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
96,533,000
91,038,000
98,264,000
89,957,000
87,449,000
88,521,000
93,543,000
87,306,000
83,102,000
83,802,000
89,856,000
93,851,000
90,359,000
93,128,000
106,578,000
100,017,000
85,455,000
81,757,000
73,021,000
70,968,000
63,724,000
55,508,000
40,282,000
36,245,000
36,319,000
37,016,000
25,875,000
24,569,000
19,532,000
16,316,000
16,652,000
14,253,000
11,554,000
8,255,000
8,120,000
7,246,000
5,975,000
5,340,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.